Lipella Pharmaceuticals Inc. announced that on March 21, 2023, the board of directors of the company, pursuant to its powers under the Company's second amended and restated by-laws, appointed Daniel Cohen as a member of the Board, thereby increasing the Board membership count to seven. Mr. Cohen will serve as a director until the next annual meeting of the Company's stockholders, at which time he will stand for election until the annual meeting of the Company's stockholders following his election, or his earlier resignation, retirement or other termination of service.